Minerva Neurosciences (NERV) Goodwill & Intangibles (2013 - 2026)
Minerva Neurosciences posted quarterly Goodwill & Intangibles of $14.9 million for Q1 2026, little changed year-on-year from $14.9 million in Q1 2025, and little changed on a QoQ basis from $14.9 million in Q4 2025.
Minerva Neurosciences (NERV) has 14 years of Goodwill & Intangibles data on file, last reported at $14.9 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2026 stood at $14.9 million (changed 0.0% YoY), and the FY2025 full-year result was $14.9 million, changed 0.0% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $14.9 million, roughly flat from $14.9 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.9 million in Q1 2022 and bottomed at $14.9 million in Q3 2024.
- The 5-year median for Goodwill & Intangibles is $14.9 million (2024), against an average of $14.9 million.
- The widest annual swing landed in 2022, when Goodwill & Intangibles plunged 50.39%; it then changed 0.0% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $14.9 million in 2022, then dropped by 0.17% to $14.9 million in 2023, then dropped by 0.11% to $14.9 million in 2024, then changed by 0.0% to $14.9 million in 2025, then changed by 0.0% to $14.9 million in 2026.
- The last three Goodwill & Intangibles figures came in at $14.9 million (Q1 2026), $14.9 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.87 Mn |
| Dec 31, 2025 | 14.87 Mn |
| Sep 30, 2025 | 14.87 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 14.87 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 14.87 Mn |
| Jun 30, 2024 | 14.87 Mn |
| Mar 31, 2024 | 14.88 Mn |
| Dec 31, 2023 | 14.89 Mn |
| Sep 30, 2023 | 14.89 Mn |
| Jun 30, 2023 | 14.90 Mn |
| Mar 31, 2023 | 14.91 Mn |
| Dec 31, 2022 | 14.91 Mn |
| Sep 30, 2022 | 14.92 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 14.92 Mn |
| Dec 31, 2021 | 14.92 Mn |
| Sep 30, 2021 | 30.07 Mn |
| Jun 30, 2021 | 30.07 Mn |
| Mar 31, 2021 | 30.07 Mn |
| Dec 31, 2020 | 30.07 Mn |
| Sep 30, 2020 | 30.07 Mn |
| Jun 30, 2020 | 30.07 Mn |
| Mar 31, 2020 | 30.07 Mn |
| Dec 31, 2019 | 30.07 Mn |
| Sep 30, 2019 | 49.07 Mn |
| Jun 30, 2019 | 49.07 Mn |
| Mar 31, 2019 | 49.07 Mn |
| Dec 31, 2018 | 49.07 Mn |
| Sep 30, 2018 | 49.07 Mn |
| Jun 30, 2018 | 49.07 Mn |
| Mar 31, 2018 | 49.07 Mn |
| Dec 31, 2017 | 49.07 Mn |
| Sep 30, 2017 | 49.07 Mn |
| Jun 30, 2017 | 49.07 Mn |
| Mar 31, 2017 | 49.07 Mn |
| Dec 31, 2016 | 49.07 Mn |
| Sep 30, 2016 | 49.07 Mn |
| Jun 30, 2016 | 49.07 Mn |
| Mar 31, 2016 | 49.07 Mn |
| Dec 31, 2015 | 49.07 Mn |
| Sep 30, 2015 | 49.07 Mn |
| Jun 30, 2015 | 49.07 Mn |
| Mar 31, 2015 | 49.07 Mn |
| Dec 31, 2014 | 49.07 Mn |
| Sep 30, 2014 | 49.07 Mn |
| Jun 30, 2014 | 49.30 Mn |
| Dec 31, 2013 | 26.92 Mn |